Corticobasal Degeneration Latest Advances

FDG PET in Movement Disorders and Parkinsonian Syndromes.

Journal: PET clinics

Published: June 18, 2026

Pearls & Oy-Sters: Plantar Agraphesthesia in Corticobasal Syndrome.

Journal: Neurology

Published: May 15, 2026

Deciphering Freezing of Gait: What Neuropathology Reveals About an Episodic Phenomenon.

Journal: The European journal of neuroscience

Published: April 30, 2026

Clinical practice guideline for integrated PET/MRI in Parkinson's disease (2026 edition)

Journal: Zhonghua yi xue za zhi

Published: April 28, 2026

Behavioral variant frontotemporal dementia initially diagnosed by long-standing walking habit: an autopsy case

Journal: Rinsho shinkeigaku = Clinical neurology

Published: April 23, 2026

Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 15, 2026

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights.

Journal: International journal of molecular sciences

Published: March 14, 2026

Brain Metabolic Signatures of Amyloid-β and Tau Pathology in Corticobasal Syndrome: A Multimodal Biomarker Study.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 11, 2026

Distinct tau filament folds in familial frontotemporal dementia due to the MAPT S305I mutation.

Journal: bioRxiv : the preprint server for biology

Published: February 23, 2026

Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations.

Journal: Frontiers in molecular neuroscience

Published: February 23, 2026

The Possible Significance of Proteomics in Understanding Molecular Mechanisms of Progressive Supranuclear Palsy, Corticobasal Degeneration, Multiple System Atrophy, and Dementia with Lewy Bodies.

Journal: Cells

Published: February 16, 2026

Corticobasal Degeneration Latest Advances

Find the Latest Research About Corticobasal Degeneration

FDG PET in Movement Disorders and Parkinsonian Syndromes.

FDG PET in Movement Disorders and Parkinsonian Syndromes.

Pearls & Oy-Sters: Plantar Agraphesthesia in Corticobasal Syndrome.

Pearls & Oy-Sters: Plantar Agraphesthesia in Corticobasal Syndrome.

Deciphering Freezing of Gait: What Neuropathology Reveals About an Episodic Phenomenon.

Deciphering Freezing of Gait: What Neuropathology Reveals About an Episodic Phenomenon.

Clinical practice guideline for integrated PET/MRI in Parkinson's disease (2026 edition)

Clinical practice guideline for integrated PET/MRI in Parkinson's disease (2026 edition)

Behavioral variant frontotemporal dementia initially diagnosed by long-standing walking habit: an autopsy case

Behavioral variant frontotemporal dementia initially diagnosed by long-standing walking habit: an autopsy case

Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges.

Rhizomes as Multi-Target Pharmacological Platforms Against Tauopathy: Neuro-Metabolic Crosstalk, Drug-Likeness, and Translational Challenges.

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights.

Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights.

Brain Metabolic Signatures of Amyloid-β and Tau Pathology in Corticobasal Syndrome: A Multimodal Biomarker Study.

Brain Metabolic Signatures of Amyloid-β and Tau Pathology in Corticobasal Syndrome: A Multimodal Biomarker Study.

Distinct tau filament folds in familial frontotemporal dementia due to the MAPT S305I mutation.

Distinct tau filament folds in familial frontotemporal dementia due to the MAPT S305I mutation.

Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations.

Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations.

The Possible Significance of Proteomics in Understanding Molecular Mechanisms of Progressive Supranuclear Palsy, Corticobasal Degeneration, Multiple System Atrophy, and Dementia with Lewy Bodies.

The Possible Significance of Proteomics in Understanding Molecular Mechanisms of Progressive Supranuclear Palsy, Corticobasal Degeneration, Multiple System Atrophy, and Dementia with Lewy Bodies.